CR20220157A - Procedimiento para preparar (4s)–4–(4–ciano–2–metoxi–fenil)–5–etoxi–2,8–dimetil–1,4–dihidro–1,6–naftiridin–3–carboxilato de 2–cianoetilo mediante separación de racematos utilizando ésteres diastereoméricos de ácido tartárico - Google Patents

Procedimiento para preparar (4s)–4–(4–ciano–2–metoxi–fenil)–5–etoxi–2,8–dimetil–1,4–dihidro–1,6–naftiridin–3–carboxilato de 2–cianoetilo mediante separación de racematos utilizando ésteres diastereoméricos de ácido tartárico

Info

Publication number
CR20220157A
CR20220157A CR20220157A CR20220157A CR20220157A CR 20220157 A CR20220157 A CR 20220157A CR 20220157 A CR20220157 A CR 20220157A CR 20220157 A CR20220157 A CR 20220157A CR 20220157 A CR20220157 A CR 20220157A
Authority
CR
Costa Rica
Prior art keywords
tartaric acid
naphthyridine
cyanoethyl
racemates
dihydro
Prior art date
Application number
CR20220157A
Other languages
English (en)
Inventor
Kai Lovis
Johannes Platzek
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CR20220157A publication Critical patent/CR20220157A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00—Preparation of esters of carbonic or haloformic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • C07C69/70—Tartaric acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/78—Benzoic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a las sales diastereoisómeras (Va), (Vb), (Vc) y/o (Vd), un procedimiento para preparar las sales diastereoisómeras (Va), (Vb), (Vc) y/o (Vd) usando un éster de ácido tartárico sustituido quiral de la fórmula (IIIa) o (IIIb), un procedimiento para preparar el compuesto de la fórmula (IVa) usando las sales diastereoisómeras (Va), (Vb), (Vc) y/o (Vd), un procedimiento para preparar el compuesto de la fórmula (VIIa) usando las sales diastereoisómeras (Va), (Vb), (Vc) y/o (Vd), un procedimiento para preparar el compuesto de la fórmula (Ia) usando las sales diastereoisómeras sales (Va), (Vb), (Vc) y/o (Vd), el uso de las sales diastereoisómeras (Va), (Vb), (Vc) y/o (Vd) para la preparación de uno de los compuestos según la fórmula (IVa), (VIIa) y/o (Ia); el uso de un éster de ácido tartárico sustituido quiralmente de la fórmula (IIIa) o (IIIb) para preparar las sales diastereoisómeras (Va), (Vb), (Vc) y/o (Vd), y el uso de un éster de ácido tartárico sustituido quiralmente de la fórmula (IIIa) o (IIIb) para preparar uno de los compuestos de la fórmula (IVa), (VIIa) y/o (Ia).
CR20220157A 2019-10-17 2020-10-12 Procedimiento para preparar (4s)–4–(4–ciano–2–metoxi–fenil)–5–etoxi–2,8–dimetil–1,4–dihidro–1,6–naftiridin–3–carboxilato de 2–cianoetilo mediante separación de racematos utilizando ésteres diastereoméricos de ácido tartárico CR20220157A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19203825 2019-10-17
PCT/EP2020/078613 WO2021074078A1 (de) 2019-10-17 2020-10-12 Verfahren zur herstellung von 2-cyanoethyl (4s)-4-(4-cyano-2-methoxy-phenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylat durch racemat-spaltung mittels diastereomerer weinsäureester

Publications (1)

Publication Number Publication Date
CR20220157A true CR20220157A (es) 2022-06-02

Family

ID=68281313

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20220157A CR20220157A (es) 2019-10-17 2020-10-12 Procedimiento para preparar (4s)–4–(4–ciano–2–metoxi–fenil)–5–etoxi–2,8–dimetil–1,4–dihidro–1,6–naftiridin–3–carboxilato de 2–cianoetilo mediante separación de racematos utilizando ésteres diastereoméricos de ácido tartárico

Country Status (15)

Country Link
US (1) US20240199599A1 (es)
EP (1) EP4045501A1 (es)
JP (1) JP7682868B2 (es)
KR (1) KR20220084103A (es)
CN (1) CN114698375B (es)
AU (1) AU2020367978A1 (es)
BR (1) BR112022005511A2 (es)
CA (1) CA3158166A1 (es)
CO (1) CO2022004446A2 (es)
CR (1) CR20220157A (es)
IL (1) IL292180B1 (es)
JO (1) JOP20220089A1 (es)
MX (1) MX2022004467A (es)
PE (1) PE20221322A1 (es)
WO (1) WO2021074078A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115340539B (zh) * 2022-01-19 2024-02-27 奥锐特药业股份有限公司 制备非奈利酮及其中间体的方法
CN115340540A (zh) * 2022-01-20 2022-11-15 奥锐特药业股份有限公司 制备非奈利酮及其中间体的方法
EP4511365A1 (en) 2022-04-18 2025-02-26 Teva Pharmaceuticals International GmbH Processes for the preparation of finerenone
EP4526302A1 (en) * 2022-05-16 2025-03-26 Alivus Life Sciences Limited Process for the preparation of finerenone and intermediates thereof
CN115322194B (zh) * 2022-08-23 2024-04-09 浙江国邦药业有限公司 一种非奈利酮中间体羧酸拆分方法
CN120607528A (zh) * 2022-08-30 2025-09-09 杭州科巢生物科技有限公司 非奈利酮的制备方法及其关键手性中间体
JP2025537211A (ja) * 2022-11-04 2025-11-14 ナンジン ブイケア ファーマテック カンパニー リミテッド ジアステレオマー酒石酸エステルによりラセミ体を分割することによりフィネレノンを調製する方法
WO2024147053A1 (en) * 2023-01-03 2024-07-11 Optimus Drugs Pvt Ltd Improved process for the preparation of finerenone
CN116041347B (zh) * 2023-01-12 2025-12-09 上海新礼泰药业有限公司 非奈利酮中间体的制备方法
CN116082334B (zh) * 2023-01-12 2025-12-09 上海新礼泰药业有限公司 非奈利酮及其中间体的制备方法
CN116218942B (zh) * 2023-03-07 2025-07-25 常州制药厂有限公司 一种非奈利酮关键中间体及成品的制备方法
CN116715663A (zh) * 2023-05-19 2023-09-08 奥锐特药业股份有限公司 一种非奈利酮及其中间体的制备方法
CN116715664B (zh) * 2023-06-12 2025-01-17 常州制药厂有限公司 一种非奈利酮关键中间体的制备方法
CN118026867B (zh) * 2024-04-12 2024-09-13 南京道尔医药研究院有限公司 一种制备2-(1r,5s,6s)-6-(氨甲基)-3-乙基双环[3.2.0]庚烷-3-烯-6-乙酸的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906460C1 (es) * 1989-03-01 1990-11-15 Goedecke Ag, 1000 Berlin, De
DE69517810T2 (de) * 1994-05-16 2000-12-14 Merrell Pharmaceuticals Inc., Cincinnati Verfahren und diastereomere salze nützlich bei der racemattrennung von racemischer 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylphenyl essigsäure sowie entsprechende diastereomere salze
US20050026886A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
BRPI0615775B1 (pt) * 2005-09-16 2021-08-10 Daiichi Sankyo Company, Limited Processos para a produção de compostos derivados de diamida oticamente ativos
DE102007009494A1 (de) * 2007-02-27 2008-08-28 Bayer Healthcare Ag Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung
HRP20201800T1 (hr) * 2014-08-01 2020-12-25 Bayer Pharma Aktiengesellschaft Postupak za pripravu (4s)-4-(4-cijano-2-metoksifenil)-5-etoksi-2,8-dimetil-1,4-dihidro-1-6-naftiridin-3-karboksamida i njegovo pročišćavanje za upotrebu kao aktivni farmaceutski sastojak
WO2017032678A1 (de) * 2015-08-21 2017-03-02 Bayer Pharma Aktiengesellschaft Verfahren zur herstellung von (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxamid und wiedergewinnung von (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxamid mittels elektrochemischer methoden
CN106432199B (zh) 2016-09-23 2019-04-26 南昌市博泽康医药科技有限公司 一种光学纯昂丹司琼及其衍生盐的制备工艺

Also Published As

Publication number Publication date
US20240199599A1 (en) 2024-06-20
BR112022005511A2 (pt) 2022-06-21
JOP20220089A1 (ar) 2023-01-30
IL292180B1 (en) 2026-03-01
CN114698375B (zh) 2024-08-02
MX2022004467A (es) 2022-05-03
AU2020367978A1 (en) 2022-05-12
KR20220084103A (ko) 2022-06-21
PE20221322A1 (es) 2022-09-09
WO2021074078A1 (de) 2021-04-22
EP4045501A1 (de) 2022-08-24
IL292180A (en) 2022-06-01
JP7682868B2 (ja) 2025-05-26
CN114698375A (zh) 2022-07-01
CO2022004446A2 (es) 2022-04-29
JP2022553230A (ja) 2022-12-22
CA3158166A1 (en) 2021-04-22

Similar Documents

Publication Publication Date Title
CR20220157A (es) Procedimiento para preparar (4s)–4–(4–ciano–2–metoxi–fenil)–5–etoxi–2,8–dimetil–1,4–dihidro–1,6–naftiridin–3–carboxilato de 2–cianoetilo mediante separación de racematos utilizando ésteres diastereoméricos de ácido tartárico
CR20220159A (es) Procedimiento para la preparación de (4s)–4–(4–ciano–2–metoxi–fenil)–5–hidroxi–2,8–dimetil–1,4–dihidro–1,6–naftiridin–3–carboxilato de 2–cianoetilo por separación de racematos por medio de éster de ácido tartárico diastereoisómero
AR090293A1 (es) Inhibidores de quinasa a base de arileter
PH12013501197B1 (en) Indeno-fused ring compounds
PE20200008A1 (es) Isoquinolinas como inhibidores de hpk1
PH12013501196B1 (en) Indeno- fused ring compounds having photochromic properties
PH12018500106A1 (en) Ethynyl derivatives as metabotropic glutamate receptor modulators
ECSP034475A (es) Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1
AR084553A1 (es) DERIVADOS IMIDAZOLICOS HETEROCICLICOS INHIBIDORES DE b-SECRETASA, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y USO DE LOS MISMOS PARA TRATAR ENFERMEDADES NEURODEGENERATIVAS, EN PARTICULAR ALZHEIMER
EA200970493A1 (ru) Макроциклические ингибиторы вируса гепатита с
AR080878A1 (es) Derivados heterociclicos de ariletinilo, composiciones farmaceuticas que los contienen, metodo para prepararlos y uso de los mismos en el tratamiento de la esquizofrenia y trastornos cognitivos.
CY1108557T1 (el) Ν-οξειδια ως ανταγωνιστες υποδοχεων νκ1, προφαρμακα παραγωγων της 4-φαινυλο-πυριδινης
EA200970266A1 (ru) Азабициклические соединения в качестве ингибиторов повторного поглощения моноаминов
AR061615A1 (es) Moduladores de receptores metabotropicos de glutamato
RU2014121205A (ru) Производные азолов
AR087915A1 (es) N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1
AR088246A1 (es) Derivados de etinilo
MY163164A (en) Ethynyl derivatives as positive allosteric modulators of the mglur5
CR20220158A (es) Procedimiento fotoquímico para la preparación de (4r,4s)–4–(4–ciano–2–metoxifenil)–5–etoxi–2,8–dimetil–1,4–dihidro–1,6–naftiridin–3–carboxamida
AR105889A1 (es) Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
AR116906A1 (es) Derivados de heteroarilo bicíclico
AR063374A1 (es) Derivados de benzoxazina y sus usos
AR077820A1 (es) Inhibidores de las jnk
ATE428693T1 (de) Prostaglandinsynthese
AR106475A1 (es) Derivados de piridina o de pirimidina